Sargent Bickham Lagudis LLC Merck & Co., Inc. Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 24,824 shares of MRK stock, worth $2.88 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
24,824
Previous 24,645
0.73%
Holding current value
$2.88 Million
Previous $2.12 Million
29.67%
% of portfolio
0.23%
Previous 0.19%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,828Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$28.3 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$24 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.6 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.4 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.61 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $293B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...